1. Home
  2. NXST vs GKOS Comparison

NXST vs GKOS Comparison

Compare NXST & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nexstar Media Group Inc.

NXST

Nexstar Media Group Inc.

HOLD

Current Price

$187.57

Market Cap

6.2B

Sector

Industrials

ML Signal

HOLD

Logo Glaukos Corporation

GKOS

Glaukos Corporation

HOLD

Current Price

$113.91

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NXST
GKOS
Founded
1996
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Broadcasting
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.0B
IPO Year
2002
2015

Fundamental Metrics

Financial Performance
Metric
NXST
GKOS
Price
$187.57
$113.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$263.75
$126.92
AVG Volume (30 Days)
278.7K
908.7K
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.67%
N/A
EPS Growth
N/A
N/A
EPS
5.09
N/A
Revenue
$4,949,000,000.00
$507,442,000.00
Revenue This Year
$11.38
$23.32
Revenue Next Year
N/A
$27.43
P/E Ratio
$37.19
N/A
Revenue Growth
N/A
32.33
52 Week Low
$164.00
$73.16
52 Week High
$254.30
$148.11

Technical Indicators

Market Signals
Indicator
NXST
GKOS
Relative Strength Index (RSI) 37.28 36.00
Support Level $182.45 $113.00
Resistance Level $210.51 $125.47
Average True Range (ATR) 8.22 7.24
MACD -0.80 -2.77
Stochastic Oscillator 13.44 22.09

Price Performance

Historical Comparison
NXST
GKOS

About NXST Nexstar Media Group Inc.

Nexstar is the largest television station owner-operator in the United States with over 200 stations in 116 markets, reaching 220 million people. Of its 200 stations, 155 are affiliated with the four national broadcast networks: CBS, Fox, NBC, and ABC. Pending approval, Nexstar's merger with Tegna would bring Nexstar's station total to 259 in 133 markets, reaching 80% of the US population. Nexstar also owns NewsNation (formerly WGN), a cable news network, 75% of the fifth national broadcaster, the CW, and a 31% stake in Food Network and Cooking Channel.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. The company has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: